Financials in USD. Standardized financial statements.
A compact view of how biote Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $192.22M | $197.19M | $185.36M | $164.96M | $139.40M | $116.57M | $109.98M |
| Revenue Growth? | -2.5% | +6.4% | +12.4% | +18.3% | +19.6% | +6.0% | 0.0% |
| Cost of Revenue? | $58.13M | $58.13M | $57.88M | $54.58M | $48.82M | $44.93M | $43.56M |
| Gross Profit? | $134.09M | $139.06M | $127.48M | $110.38M | $90.58M | $71.64M | $66.41M |
| Gross Margin? | +69.8% | +70.5% | +68.8% | +66.9% | +65.0% | +61.5% | +60.4% |
| Operating Expenses? | $94.97M | $107.45M | $98.83M | $171.10M | $56.02M | $39.86M | $42.88M |
| Operating Income? | $39.12M | $31.61M | $28.66M | -$60.72M | $34.56M | $31.78M | $23.53M |
| EBITDA? | $42.79M | $15.59M | $39.54M | $7.96M | $35.98M | $32.91M | $24.29M |
| Income Before Tax | $37.58M | $1.02M | -$123,000 | $1.71M | $32.91M | $29.35M | $21.38M |
| Income Tax Expense | $5.99M | $970,000 | $2.68M | $388,000 | $286,000 | $189,000 | $93,000 |
| Net Income? | $27.05M | $3.16M | $3.32M | -$969,000 | $32.62M | $29.16M | $21.29M |
| EPS? | $0.86 | $0.09 | $0.13 | $0.16 | $-0.87 | $3.85 | $2.81 |
| Diluted EPS? | $0.74 | $0.09 | $0.13 | $0.16 | $-0.87 | $3.85 | $2.81 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality